Isracann Bioscience-Accelerated Genetics Arrives in Israel, The Canadian Business Journal

VANCOUVER, British Columbia, September 28, 2022 (GLOBE NEWSWIRE) — Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (“Company”) A multi-faceted Israel-based company focused on becoming the best low-cost, high-quality cannabis producer/distributor ensures that previously shipped genes clear Israeli customs and are I am pleased to announce that it is being raised as a stock.

“The Israeli market now has access to high THC genetics from Canada,” said CEO Phil Floucoult. “The three strains of his that we have shipped are called Liberty Haze, Hell Monkey and Grape Stomper. I look forward to what I can do.”

The three strains sent were developed as part of United Greeneries’ “grassroots” genetics program, whose aim is to produce new high-THC strains at commercially high yields. Three strains currently sold as premium cannabis flowers in Canada represent the best genetics in the United Greeneries catalog. With the support of United Greeneries and Isracann, all three strains have been integrated into his Intelicanna facility and are being prepared as the first Israeli mother strains.

Phil Fourcaut continues. The growing team is now fully engaged and working to expedite the scaling process to full production. In the near future, Canadian quality cannabis will be grown in Israel and made available to Israeli customers. Canadian genetics, raised in Israel. ”

On behalf of the Board of Directors

“Phil Fourcaut”

Phil Fourcaut
Chief Executive Officer and President

About Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF)
Isracann is a multidisciplinary cannabis-focused grower and product developer with Israel-based cannabis production farm assets and a natural health medicine development and production division in Canada. At the same time, by focusing on first retail sales in Canada and becoming the premier cannabis grower offering low-cost domestic Israeli production, the company will commercialize natural health medicines in Canada, creating import/export opportunities and It aims to leverage contracts within Israel for medical marijuana cultivation. For more information, please visit www.isracann.com.

contact
Empire Communications Group
+1 (604) 343-2724
[email protected]
www.isracann.com

Forward-Looking Information
This release may contain forward-looking statements. Forward-looking statements are not historical facts and are generally, but not always, “expects”, “plans”, “expects”, “believes”, “intends”, “estimates” ”, a description identified by the word “project”. , “potentially” and similar expressions, or that an event or condition “occurs”, “would”, “could”, “could” or “should occur”. Forward-looking statements include, but are not limited to, statements regarding commercial production of Liberty Haze, Hell Monkey and Grape Stomper for the Israeli market. Any forward-looking statements contained in this press release are qualified in their entirety by this cautionary statement. All forward-looking statements contained in this press release are made as of the date of this press release. The forward-looking statements contained herein are generally made by CSE, the British Columbia Securities Commission, the Alberta Securities Commission and the Ontario Securities Commission. Isracann believes that the expectations expressed in such forward-looking statements are based on reasonable assumptions, but such statements are not guarantees of future performance and actual results may vary. They may differ materially from forward-looking statements. Isracann expressly disclaims any intention or obligation to update or revise any forward-looking statements as a result of new information, future events or otherwise.

CSE does not take responsibility for the adequacy or accuracy of this release.

CBJ Newsmaker